BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 25461321)

  • 1. Discovery of non-oxime reactivators using an in silico pharmacophore model of reactivators for DFP-inhibited acetylcholinesterase.
    Bhattacharjee AK; Marek E; Le HT; Ratcliffe R; DeMar JC; Pervitsky D; Gordon RK
    Eur J Med Chem; 2015 Jan; 90():209-20. PubMed ID: 25461321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of non-oxime reactivators using an in silico pharmacophore model of oxime reactivators of OP-inhibited acetylcholinesterase.
    Bhattacharjee AK; Marek E; Le HT; Gordon RK
    Eur J Med Chem; 2012 Mar; 49():229-38. PubMed ID: 22309910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In silico pharmacophore model for tabun-inhibited acetylcholinesterase reactivators: a study of their stereoelectronic properties.
    Bhattacharjee AK; Kuca K; Musilek K; Gordon RK
    Chem Res Toxicol; 2010 Jan; 23(1):26-36. PubMed ID: 20028185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro reactivation kinetics of paraoxon- and DFP-inhibited electric eel AChE using mono- and bis-pyridinium oximes.
    Gupta B; Sharma R; Singh N; Kuca K; Acharya JR; Ghosh KK
    Arch Toxicol; 2014 Feb; 88(2):381-90. PubMed ID: 24065055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyridinium oxime reactivators of cholinesterase inhibited by diisopropyl-fluorophosphate (DFP): predictive value of in-vitro testing for in-vivo efficacy.
    Petroianu GA; Lorke DE
    Mini Rev Med Chem; 2008 Nov; 8(13):1328-42. PubMed ID: 18991751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and evaluation of novel bis-pyridinium oximes as reactivators of DFP-inhibited acetylcholinesterase.
    Acharya J; Gupta AK; Dubey DK; Raza SK
    Eur J Med Chem; 2009 Mar; 44(3):1335-40. PubMed ID: 18396353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro oxime protection of human red blood cell acetylcholinesterase inhibited by diisopropyl-fluorophosphate.
    Lorke DE; Hasan MY; Arafat K; Kuca K; Musilek K; Schmitt A; Petroianu GA
    J Appl Toxicol; 2008 May; 28(4):422-9. PubMed ID: 18344198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo protection of diisopropylphosphorofluoridate (DFP) poisoning by three bis-quaternary 2 -(hydroxyimino) -N -(pyridin-3-yl) acetamide derivatives in Swiss mice.
    Kumar P; Swami D; Karade HN; Acharya J; Jatav PC; Kumar A; Meena MK
    Cell Mol Biol (Noisy-le-grand); 2014 Oct; 60(3):53-9. PubMed ID: 25346249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In silico pharmacophore modeling on known pyridinium oxime reactivators of cyclosarin (GF) inhibited AChE to Aid discovery of potential, more efficacious novel non-oxime reactivators.
    Bhattacharjee AK; Musilek K; Kuca K
    Curr Comput Aided Drug Des; 2013 Sep; 9(3):402-11. PubMed ID: 23789829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of reversible ligands on oxime-induced reactivation of sarin- and cyclosarin-inhibited human acetylcholinesterase.
    Scheffel C; Thiermann H; Worek F
    Toxicol Lett; 2015 Feb; 232(3):557-65. PubMed ID: 25522658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactivation of DFP- and paraoxon-inhibited acetylcholinesterases by pyridinium oximes.
    Oh KA; Park NJ; Park NS; Kuca K; Jun D; Jung YS
    Chem Biol Interact; 2008 Sep; 175(1-3):365-7. PubMed ID: 18565503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions between xylene-linked carbamoyl bis-pyridinium mono-oximes and organophosphates inhibited-AChE: a kinetic study.
    Sharma R; Gupta B; Acharya J; Kaushik MP; Ghosh KK
    Toxicology; 2014 Feb; 316():1-8. PubMed ID: 24345352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel oximes as blood-brain barrier penetrating cholinesterase reactivators.
    Garcia GE; Campbell AJ; Olson J; Moorad-Doctor D; Morthole VI
    Chem Biol Interact; 2010 Sep; 187(1-3):199-206. PubMed ID: 20227398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzyme-kinetic investigation of different sarin analogues reacting with human acetylcholinesterase and butyrylcholinesterase.
    Bartling A; Worek F; Szinicz L; Thiermann H
    Toxicology; 2007 Apr; 233(1-3):166-72. PubMed ID: 16904809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A common mechanism for resistance to oxime reactivation of acetylcholinesterase inhibited by organophosphorus compounds.
    Maxwell DM; Brecht KM; Sweeney RE
    Chem Biol Interact; 2013 Mar; 203(1):72-6. PubMed ID: 22982773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of a potent non-oxime reactivator of nerve agent inhibited human acetylcholinesterase.
    de Koning MC; Horn G; Worek F; van Grol M
    Eur J Med Chem; 2018 Sep; 157():151-160. PubMed ID: 30096649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential acetylcholinesterase reactivators: oxime and amidoxime derivatives.
    Serafin B; Majewski M; Kleinrok Z; Jagiełło-Wojtowicz E; Rajtar G; Sieklucka-Dziuba M; Kolasa K
    Arch Immunol Ther Exp (Warsz); 1976; 24(6):901-10. PubMed ID: 1015993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonquaternary reactivators for organophosphate-inhibited cholinesterases.
    Kalisiak J; Ralph EC; Cashman JR
    J Med Chem; 2012 Jan; 55(1):465-74. PubMed ID: 22206546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reactivation of organophosphate-inhibited human acetylcholinesterase by isonitrosoacetone (MINA): a kinetic analysis.
    Worek F; Thiermann H
    Chem Biol Interact; 2011 Nov; 194(2-3):91-6. PubMed ID: 21930118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Five oximes (K-27, K-33, K-48, BI-6 and methoxime) in comparison with pralidoxime: in vitro reactivation of red blood cell acetylcholinesterase inhibited by paraoxon.
    Petroianu GA; Arafat K; Kuca K; Kassa J
    J Appl Toxicol; 2006; 26(1):64-71. PubMed ID: 16193529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.